COLLPLANT BIOTECH. IS-01 (CPT) — Financial Flexibility Index

Latest as of December 2025: -0.62x

COLLPLANT BIOTECH. IS-01 (CPT) has a Financial Flexibility Index of -0.62x as of December 2025. Free cash flow of €-2.92 Million (operating CF €-2.94 Million minus capex €15.00K) represents -1% of total liabilities (€4.70 Million). Check COLLPLANT BIOTECH. IS-01 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

-0.62x
Free Cash Flow / Total Liabilities

Free Cash Flow

€-2.92 Million
Operating CF − Capex

Total Liabilities

€4.70 Million
EUR

Capital Expenditures

€15.00K
EUR

COLLPLANT BIOTECH. IS-01 Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for COLLPLANT BIOTECH. IS-01 across 5 annual periods. For the full cash flow conversion analysis, see CPT operating cash flow.

Annual Financial Flexibility Index for COLLPLANT BIOTECH. IS-01 (2021–2025)

Year-by-year free cash flow to debt coverage for COLLPLANT BIOTECH. IS-01. Explore CPT operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2025 -2.00x €-9.39 Million €-9.42 Million €4.70 Million ▲ +23.1%
2024 -2.59x €-13.61 Million €-14.09 Million €5.25 Million ▼ -730.0%
2023 -0.31x €-1.81 Million €-2.76 Million €5.79 Million ▲ +86.1%
2022 -2.26x €-12.38 Million €-13.70 Million €5.49 Million ▼ -436.7%
2021 0.67x €4.09 Million €2.50 Million €6.10 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities